"If approved, the company ... at Weill Cornell Medicine, calls the new drug "transformational." Aronne has been treating obesity for 35 years and is a consultant for Eli Lilly.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Eli Lilly (NYSE:LLY) and its peers. The branded pharmaceutical ...

That would be Eli Lilly, Mastercard, McDonald's. Eli Lilly announcing first quarter earnings in the morning. Company's busy drug pipeline will be in focus. Investors will listen closely for any ...

Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity of GLP-1 drugs. The pharmaceutical company has no plans of slowing down ...

It warned of continued challenges in the company’s Aesthetics unit, citing macroeconomic softness and rising competition. In contrast, Goldman upgraded Eli Lilly to Buy from Neutral, maintaining ...

(CNN) — Drugmaker Eli Lilly ... effects. Lilly says that no such diet restrictions are needed with its experimental oral medication, orforglipron, and that it’s the first drug of its kind to complete ...

Work could start as early as this year on a huge new manufacturing facility for Eli Lilly in Limerick ... ingredients for Lilly medicines is on track to start in 2026. The Limerick plant will ...

We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra. In this article, we will summarize the ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential.